Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × anetumab ravtansine × Clear all

NCT03023722 2021-10-28

Phase II Anetumab Ravtansine in Pre-treated Mesothelin-expressing Pancreatic Cancer

Phase 2 Completed

18 enrolled 10 charts

Gastrointestinal

Pancreatic Neoplasms